Council for Tobacco Research
1975 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
Abstract
MAR
Fields
- Depository Date
- 25 Sep 1995
- Master ID
- Ctrmn00000667-6967
Related Documents:- CTRMN000667-0808 Deposition of Robert F. Gertenbach [Deposition of Gertenbach in the Matter of Rogers]
- CTRMN000809-0827 Certificate of Incorporation of the Council for Tobacco Research - U.S.A., Inc. Under Section 402 of the Not-for-Profit Corporation Law [Details Definitions and Purposes for Forming A Not-for-Profit Corporation]
- CTRMN000828-0848 by-Laws of the Council for Tobacco Research - U.S.A., Inc. [Rules and Regulations for the Operation of the Council]
- CTRMN000849-0854 Application for Research Grant [A Blank Funding Request Form for Scientific Studies]
- CTRMN000855-0856 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Stipulations for Receiving A Funding Award]
- CTRMN000857-0859 [Suggestions and Guidelines for Submitting A Request for A Grant]
- CTRMN000860-0871 [Transmittal of Information for Securing A Research Grant]
- CTRMN000872-0882 [A Blank Funding Request Form for Scientific Studies]
- CTRMN000883-0892 Closing Dates for Application of Renewal Grants Requirements: (1) Progress Report and (2) Abstract of Progress Report [Procedural Information for Applying for Continued Funding for Scientific Project]
- CTRMN000893-1031 Published Reports on Research Supported in Whole or in Part by the Council for Tobacco Research - U.S.A. Formerly the Tobacco Industry Research Committee [List of Scientific Studies]
- CTRMN001032-1045 1956 Report of the Scientific Director [St]
- CTRMN001046-1094 1957 Report of the Scientific Director [St]
- CTRMN001095-1127 1958 Report of the Scientific Director [St]
- CTRMN001128-1163 1959 Report of the Scientific Director [St]
- CTRMN001164-1201 1960 Report of the Scientific Director [St]
- CTRMN001202-1239 1961 Report of the Scientific Director [St]
- CTRMN001240-1269 1962 Report of the Scientific Director [St]
- CTRMN001270-1306 Annual Report of the Scientific Director [St]
- CTRMN001307-1346 Report of the Scientific Director [St]
- CTRMN001347-1387 Report of the Scientific Director [St]
- CTRMN001388-1429 Report of the Scientific Director [St]
- CTRMN001430-1485 Annual Report of the Scientific Director [St]
- CTRMN001486-1529 Report of the Scientific Director [St]
- CTRMN001530-1578 Annual Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001579-1632 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001633-1681 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001682-1727 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001772-1816 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001817-1860 1977 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001861-1913 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001914-1967 1979 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001968-2025 1980 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002026-2088 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002089-2148 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002149-2223 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002224-2942 Application for Research Grant An Investigation of the Spectral and Chromatographic Characteristics of Aromatic Hydrocarbons. [Study on High Temperature Gas-Liquid Partition Chromatography]
- CTRMN002943-3303 [Regarding Polio and Tuberculosis As Predisposing Factor in Lung Cancer]
- CTRMN003304-3322 Tobacco-Health Research Program [Display Case Showing Main Areas of Investigation]
- CTRMN003323-3326 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Rules for Approval of Grants Relating to Tobacco Use and Human Health]
- CTRMN003327-3337 A Brief Review of the Smoking-Lung Cancer Theory [Concerning Problems of Cigarette Lung Cancer Causation and Why They Have No Been Solved]
- CTRMN003338-3357 A Scientific Perspective on the Cigarette Controversy [Views of Cancer Experts on Causes of Lung Cancer]
- CTRMN003358-3365 Some Information About... The Council for Tobacco Research-U.S.A., Inc. ...and Its Research Program [Informs About the Purpose and Function of Organization's Research Program]
- CTRMN003366-3374 the Research Program of the Scientific Advisory Board to the Council for Tobacco Research - U.S.A. [Informs the Purposes, Policies, and the Research Program of the Board]
- CTRMN003375-3419 the Cancer-Smoking Controversy [Regards the Fallacious Conclusions of Cigarette Smoking Causing Lung Cancer From A Mathematical and Scientific Point of View]
- CTRMN003420-3425 Some Harvard Men & the Smoking Habit [Give Results of Questionnaire Relating to Biological Factors of Tobacco Smoking]
- CTRMN003426-3431 the Pathologic Anatomy of the Bronchial Tree and Lungs Reprinted From the Archives of Pathology Vol. 70 [St Finds of Equivocal Results with the Use of Tobacco]
- CTRMN003432-3437 Some Statistical Observations on A Co-Operative Study of Human Pulmonary Pathology Reprinted From the Proceedings of the National Academy of Sciences Vol. 43 No. 12 [St Examines Systematically the Conditions at Autopsy in the Bronchial Mucosae of Random Cases]
- CTRMN003438-3442 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology, II [Results Show Pathological Lungs in Different Cities Are Acutally Different]
- CTRMN003443-3447 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology. II [Study Comparing Pathological Conditions in 8 Different Cities Shows That Conditions Are All Different]
- CTRMN003448-3456 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology [Systematic Examinations of the Conditions at Autopsy in the Bronchial Mucosae of Run-of-the-Mill Cases]
- CTRMN003457-3464 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology III [When Probability Is Doubtful the Use of Variable Tables to Calculate Results Is the Best Way to Make A Precise and Accurate Answer for Sufficient Range of Pathological Conditions]
- CTRMN003465-3476 Differences Between Smokers and Nonsmokers [Differences Between Smokers and Nonsmokers Have to Do with Personality Traits and Physiologic Criteria]
- CTRMN003477-3485 the Psychology of Smoking [Smoking Is Determined by Certain Personality Variables and Personal Needs]
- CTRMN003486-3490 the Tobacco and Health Research Program of the Scientific Advisory Board [Regarding Information the Tobacco Industry Research Committee Do for the Research Program]
- CTRMN003491-3558 Tobacco Consumption in Various Countries [Results of Cigarette and Cigar Smokers From Different Countries]
- CTRMN003559-3560 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Guidelines for Which Grants Are Approved]
- CTRMN003561-3780 Tobacco Smoking in the United States in Relation to Income Marketing Research Report No. 189 [A Report Compiled by the Bureau of the Census for the United States Public Health Service on Smoking Characteristics in Relation to Income, Age, Region, Urban-Rural Residence and Occupation.]
- CTRMN003781-3781 Operating Results 1982 and Budget 1983 [Record of Expenditures]
- CTRMN003782-3782 Operating Results for Ten-Months Ended 10/31 Budget 11/1/83 Through 10/31/84 [Record of Expenditures]
- CTRMN003783-3783 Actual Operating Fiscal Year 1984 and Budget Fiscal Year 1985 [Record of Expenditures]
- CTRMN003784-3787 Confidential Report on Meeting January 18, 1954 Tobacco Industry Research Committee (TIRC) [St]
- CTRMN003788-3797 Confidential Report on Meeting March 15, 1954 Tobacco Industry Research Committee [St]
- CTRMN003798-3800 Tobacco Industry Research Committee Meeting [St]
- CTRMN003801-3815 Tobacco Industry Research Committee Meeting [St]
- CTRMN003816-3835 Tobacco Industry Research Committee Meeting [St]
- CTRMN003836-3852 Tobacco Industry Research Committee Meeting November 3, 1955 [St]
- CTRMN003853-3869 Tobacco Industry Research Committee Meeting February 14, 1956 [St]
- CTRMN003870-3895 Tobacco Industry Research Committee Meeting October 9, 1956 [St]
- CTRMN003896-3907 Tobacco Industry Research Committee Meeting May 9, 1957 [St]
- CTRMN003908-3923 Tobacco Industry Research Committee Meeting November 8, 1957 [St]
- CTRMN003924-3931 Tobacco Industry Research Committee Meeting May 8 1958 [St]
- CTRMN003932-3939 Tobacco Industry Research Committee Meeting November 6, 1958 [St]
- CTRMN003940-3945 Tobacco Industry Research Committee Meeting [St]
- CTRMN003946-3956 Tobacco Industry Research Committee Meeting December 10, 1959 [St]
- CTRMN003957-3969 Tobacco Industry Research Committee Meeting November 15, 1960 [St]
- CTRMN003970-3982 Tobacco Industry Research Committee Meeting October 18, 1961 [St]
- CTRMN003983-3991 Tobacco Industry Research Committee Meeting [St]
- CTRMN003992-4002 Tobacco Industry Research Committee Meeting November 15, 1962 [St]
- CTRMN004003-4006 the Council for Tobacco Research - U.S.A. March 5, 1964 [St]
- CTRMN004007-4014 the Council for Tobacco Research - U.S.A. June 8, 1965 [St]
- CTRMN004015-4020 the Council for Tobacco Research - U.S.A. January 27, 1967 [St]
- CTRMN004021-4026 the Council for Tobacco Research - U.S.A. January 24, 1968 [St]
- CTRMN004027-4034 the Council for Tobacco Research - U.S.A. January 31, 1969 [St]
- CTRMN004035-4041 Minutes of the First Meeting of the Board of Directors [St]
- CTRMN004042-4048 Minutes of the Second Meeting of the Board of Directors January 29, 1971 [St]
- CTRMN004049-4052 Minutes of the Meeting of the Executive Committee of the Board of Directors June 24, 1971 [St]
- CTRMN004053-4057 Minutes of of the Board of Directors January 28, 1972 [St]
- CTRMN004058-4061 Minutes of the Meeting of the Board of Directors November 10, 1972 [St]
- CTRMN004062-4066 Minutes of the Meeting of the Board of Directors January 26, 1973 [St]
- CTRMN004067-4070 Minutes of the Special Meeting of the Board of Directors July 26, 1973 [St]
- CTRMN004071-4076 Minutes of the Meeting of the Board of Directors February 1, 1974 [St]
- CTRMN004077-4081 Minutes of the Special Meeting of the Board of Directors June 13, 1974 [St]
- CTRMN004082-4086 Minutes of the Special Meeting of the Board of Directors December 5, 1974 [St]
- CTRMN004087-4091 Minutes of the Meeting of the Board of Directors January 31, 1975 [St]
- CTRMN004092-4095 Minutes of the Special Meeting of the Board of Directors July 24, 1975 [St]
- CTRMN004096-4141 Retirement Plan for Employees of the Council for Tobacco Research - U.S.A., Inc. Amended and Restated As of July 1, 1975 [St]
- CTRMN004142-4147 Minutes of the Special Meeting of the Board of Directors December 10, 1975 [St]
- CTRMN004148-4153 Minutes of the Meeting of the Board of Directors January 30, 1976 [St]
- CTRMN004154-4157 Minutes of the Special Meeting of the Board of Directors September 9, 1976 [St]
- CTRMN004158-4161 Minutes of the Meeting of the Board of Directors January 28 1977 [St]
- CTRMN004162-4166 Minutes of the Special Meeting of the Board of Directors April 21 1978 [St]
- CTRMN004167-4167 Minutes of the Special Meeting of the Executive Committee of the Board of Directors August 17, 1978 [St]
- CTRMN004168-4172 Minutes of the Meeting of the Board of Directors January 29, 1979 [St]
- CTRMN004173-4176 Minutes of the Meeting of the Board of Directors February 1, 1980 [St]
- CTRMN004177-4178 Minutes of the Board of Directors Executive Committee Meeting New York, New York [St]
- CTRMN004179-4184 Minutes of the Meeting of the Directors January 30, 1981 [St]
- CTRMN004185-4189 Minutes of the Special Meeting of the Board of Directors June 25, 1981 [St]
- CTRMN004190-4192 Minutes of A Meeting of Certain Members of the Board of Directors [St]
- CTRMN004193-4198 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004199-4205 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004206-4209 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004210-4213 Minutes of the Special Meeting of the Board of Directors [St]
- CTRMN004214-4217 Confidential Report of Scientific Advisory Board Meeting [St]
- CTRMN004218-4221 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004222-4226 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004227-4232 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004233-4236 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004237-4240 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004241-4246 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004247-4251 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004252-4256 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004257-4266 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004267-4283 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004284-4287 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004288-4292 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004293-4297 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004298-4303 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004304-4310 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004311-4316 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004317-4319 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004320-4323 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004324-4330 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004331-4335 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004336-4339 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004340-4344 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004345-4348 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004349-4353 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004354-4357 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004358-4366 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004367-4370 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004371-4376 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004377-4390 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004391-4395 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004396-4400 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004401-4404 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004405-4409 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004410-4413 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004414-4416 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004417-4420 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004421-4426 Confidential Report Scientific Board Meeting [St]
- CTRMN004427-4430 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004431-4433 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004434-4436 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004437-4439 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004440-4443 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004444-4446 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004447-4450 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004451-4454 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004455-4459 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004460-4463 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004464-4467 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004468-4472 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004473-4475 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004476-4480 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004481-4484 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004485-4492 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004493-4497 Confidential Report Scientific Advisory Board Meeting September 23-24, 1967 [St]
- CTRMN004498-4501 Confidential Report Scientific Advisory Board Meeting December 9-10, 1967 [St]
- CTRMN004502-4505 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004506-4510 Confidential Report Scientific Advisory Board Meeting La Jolla, California March 2-3-4, 1968 [St]
- CTRMN004511-4516 Confidential Report Scientific Advisory Board Meeting New York New York May 25-26, 1968 [St]
- CTRMN004517-4522 Confidential Report Scientific Advisory Board Meeting New York, New York September 14-15, 1968 [St]
- CTRMN004523-4526 Confidential Report Scientific Advisory Board Meeting New York, New York December 8-9, 1968 [St]
- CTRMN004527-4531 Confidential Report Scientific Advisory Board Meeting New York, New York March 22-23, 1969 [St]
- CTRMN004532-4538 Confidential Report Scientific Advisory Board Meeting New York, New York May 16-18, 1969 [St]
- CTRMN004539-4544 Confidential Report Scientific Advisory Board Meeting New York, New York September 12-14, 1969 [St]
- CTRMN004545-4549 Confidential Report Scientific Advisory Board Meeting New York, New York December 12-14, 1969 [St]
- CTRMN004550-4555 Confidential Report Scientific Advisory Board Meeting Colorado Springs, Colorado March 20-22, 1970 [St]
- CTRMN004556-4560 Confidential Report Scientific Advisory Board Meeting New York, New York [St]
- CTRMN004561-4569 Confidential Report Scientific Advisory Board Meeting New York, N.Y. September 18-19-20, 1970 [St]
- CTRMN004570-4578 Confidential Report Scientific Advisory Board Meeting Chicago, Illinois January 15,16, 1971 [St]
- CTRMN004579-4585 Confidential Report Scientific Advisory Board Meeting New York, N.Y. May 7-8-9, 1971 [St]
- CTRMN004586-4593 Confidential Report Scientific Advisory Board Meeting New York, N.Y. September 24-25-26, 1971 [St]
- CTRMN004594-4598 Confidential Report Scientific Advisory Board Meeting New York, N.Y. [St]
- CTRMN004599-4604 Confidential Report Scientific Advisory Board Meeting Palm Springs, California March 24-25-26, 1972 [St]
- CTRMN004605-4609 Confidential Report Scientific Advisory Board Meeting New York, New York June 9-11, 1972 [St]
- CTRMN004610-4614 Confidential Report Scientific Advisory Board Meeting New York, New York September 15-17, 1972 [St]
- CTRMN004615-4623 Confidential Report Scientific Advisory Board Meeting New York, New York March 14-15-16, 1973 [St]
- CTRMN004624-4626 Meeting Executive Committee of the Scientific Advisory Board June 13, 1973 New York, N.Y. [St]
- CTRMN004627-4634 Confidential Report Scientific Advisory Board Meeting New York, New York October 10-11-12, 1973 [St]
- CTRMN004635-4643 Meeting Executive Committee of the Scientific Advisory Board December 4, 1973 New York, N.Y. [St]
- CTRMN004644-4654 Confidential Report Scientific Advisory Board Meeting New York, New York October 30-31 November 1, 1974 [St]
- CTRMN004655-4656 Meeting Executive Committee of the Scientific Advisory Board December 13, 1974 New York, N.Y. [St]
- CTRMN004657-4664 Confidential Report Scientific Advisory Board Meeting Santa Barbara, California March 26-27-28, 1975 [St]
- CTRMN004665-4672 Confidential Report Scientific Advisory Board Meeting New York, New York September 10-11-12, 1975 [St]
- CTRMN004673-4675 Meeting Executive Committee of the Scientific Advisory Board New York, New York December 13, 1975 [St]
- CTRMN004676-4683 Confidential Report Scientific Advisory Board Meeting Santa Barbara, California March 17-18-19, 1976 [St]
- CTRMN004684-4686 Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 11, 1976 [St]
- CTRMN004687-4694 Confidential Report Scientific Advisory Board Meeting New York, New York September 28-29-30, 1976 October 1, 1976 [St]
- CTRMN004695-4697 Meeting of the Executive Committee of the Scientific Advisory Board Bethesda, Maryland December 1, 1976 [St]
- CTRMN004698-4706 Confidential Report Scientific Advisory Board Meeting Tuscon, Arizona March 23-25, 1977 [St]
- CTRMN004707-4708 Meeting of the Executive Committee of the Scientific Advisory Board Tuscon, Arizona March 25, 1977 [St]
- CTRMN004709-4710 Meeting of the Executive Committee of the Scientific Advisory Board New York, New York May 19, 1977 [St]
- CTRMN004711-4719 Confidential Report Scientific Advisory Board Meeting New York, New York October 26-28, 1977 [St]
- CTRMN004720-4723 Confidential Report Scientific Advisory Board Meeting Phoenix, Arizona January 16-17, 1978 [St]
- CTRMN004724-4724 Confidential Report Meeting of the Scientific Advisory Board Committee Phoenix, Arizona January 17, 1978 [St]
- CTRMN004725-4734 Confidential Report Scientific Advisory Board Meeting New York, New York April 26-27-28, 1978 [St]
- CTRMN004735-4735 Confidential Report Scientific Advisory Board Executive Committee New York, New York April 27, 1978 [St]
- CTRMN004736-4737 Confidential Report Meeting for the Scientific Advisory Board New York, New York July 27, 1978 [St]
- CTRMN004736A-4736A Confidential Report Meeting of the Scientific Advisory Board New York, New York July 27, 1978 [St]
- CTRMN004738-4747 Confidential Report Scientific Advisory Board Meeting New York, New York October 18-19-20, 1978 [St]
- CTRMN004748-4750 Confidential Report Meeting of the Scientific Advisory Board New York, New York December 20, 1978 [St]
- CTRMN004751-4759 Confidential Report Scientific Advisory Board Meeting New York, New York April 11-12-13, 1979 [St]
- CTRMN004760-4769 Confidential Report Scientific Advisory Board Meeting New York, New York October 17-18-19, 1979 [St]
- CTRMN004770-4770 Confidential Meeting of the Report Scientific Advisory Board New York, New York October 18, 1979 [St]
- CTRMN004771-4780 Confidential Report Scientific Advisory Meeting New York, New York Aprill 9-10-11, 1980 [St]
- CTRMN004781-4781 Confidential Report Executive Committee of the Scientific Advisory Board Meeting New York, New York June 20, 1980 [St]
- CTRMN004782-4783 Confidential Report Executive Committee of the Scientific Advisory Board Meeting New York, New York September 16, 1980 [St]
- CTRMN004784-4792 Confidential Report Scientific Advisory Board Meeting New York, New York October 8-9-10, 1980 [St]
- CTRMN004793-4794 Confidential Report Meeting of the Scientific Advisory Board New York, New York October 9, 1980 [St]
- CTRMN004795-4804 Confidential Report Scientific Advisory Board Meeting New York, New York April 8-9-10, 1981 [St]
- CTRMN004805-4805 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 8, 1981 [St]
- CTRMN004806-4806 Confidential Report Meeting of the Scientific Advisory Board New York, New York September 10, 1981 [St]
- CTRMN004807-4816 Confidential Report Scientific Advisory Board Meeting New York, New York October 14-15-16, 1981 [St]
- CTRMN004817-4818 Confidential Report Meeting of the Executive Committee Scientific Advisory Board New York, New York October 15, 1981 [St]
- CTRMN004819-4820 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York December 9, 1981 [St]
- CTRMN004821-4831 Confidential Report Scientific Advisory Board Meeting New York, New York April 21, 22, 23, 1982 [St]
- CTRMN004832-4833 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 21, 1982 [St]
- CTRMN004834-4843 Confidential Report Scientific Advisory Board Meeting New York, New York October 6,7,8, 1982 [St]
- CTRMN004844-4844 Confidential Report Meeting of the Executive Meeting of the Scientific Advisory Board New York, New York October 8, 1982 [St]
- CTRMN004845-4845 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board Scottsdale, Arizona February 24, 1983 [St]
- CTRMN004846-4857 Confidential Report Scientific Advisory Board Meeting New York, New York April 20, 21, 22, 1983 [St]
- CTRMN004858-4858 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 22, 1983 [St]
- CTRMN004859-4859 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 6, 1983 [St]
- CTRMN004860-4871 Confidential Report Scientific Advisory Board Meeting New York, New York October 12, 13, 14, 1983 [St]
- CTRMN004872-4882 Confidential Report Scientific Advisory Board Meeting New York, New York March 28, 29, 30, 1984 [St]
- CTRMN004883-4883 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York March 29, 1984 [St]
- CTRMN004884-4895 Confidential Report Scientific Advisory Board Meeting September 19, 20, 21, 1984 New York, New York [St]
- CTRMN004896-4896 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York September 20, 1984 [St]
- CTRMN004897-4897 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board Palm Beach, Florida February 25, 1985 [St]
- CTRMN004898-4898 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 16, 1985 [St]
- CTRMN004899-4910 Confidential Report Scientific Advisory Board Meeting April 15, 16, 17, 1985 New York, New York [St]
- CTRMN004911-4911 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 16, 1985 [St]
- CTRMN004912-4923 Confidential Report Scientific Advisory Board Meeting April 15, 16, 17, 1985 New York, New York [St]
- CTRMN004924-4927 for Release: A.M.'s Wednesday, April 14, 1954 ["Reaction to the Compendium "A Scientific Perspective on the Cigarette Controversy""]
- CTRMN004928-4929 for Release: A.M.'s Tuesday, April 27, 1954 [Scientific Advisory Board Organized Early to Begin Research Into All Phases of Tobacco Use and Health for the Year]
- CTRMN004930-4931 for Release in A.M.'s of Tuesday, May 18, 1954 [Proposals Submitted for Cancer Research Projects for Consideration by Scientific Advisory Board]
- CTRMN004932-4933 for Release After 10:30 A.M., June 15, 1954 [Appointment of Dr. Clarence Cook Little Announced by the Tobacco Research Industry Committee]
- CTRMN004934-4937 for Immediate Release [American Cancer Society Survey Conveys the Need to Further Research to Discover Cause of Cancer and Cardiovascular Disease]
- CTRMN004938-4939 for Release in Am's of Tuesday, July 20, 1954 [Edwin B. Wilson of Harvard University Became A Member of Scientific Advisory Board of the Tobacco Industry Research Committee]
- CTRMN004940-4942 for Release: A.M.'s of Wednesday, July 28, 1954 Little Announces Research Policy of Tobacco Industry Research Committee [Three Main Areas to Be Covered by Research Program Announced]
- CTRMN004943-4944 for Release in A.M.'s Thursday, August 19, 1954 [Dr. Julius H. Comroe of University of Pennsylvania, Accepted Membership on Scientific Advisory Board of the Tobacco Industry Research Committee]
- CTRMN004945-4945 for Immediate Release (Monday, October 11, 1954) Dr. Little Gives TIRC View [Little States That No Convincing Evidence Has Yet Been Found to Prove That Cigarette Smoking Causes Lung Cancer]
- CTRMN004946-4946 for Immediate Release (Tuesday, October 12, 1954) [Timothy V. Hartnet, Chairman of Board, Stated That Public Should Be Reminded That No Lung Cancer Causing Agent Has Yet Been Identified in Tobacco]
- CTRMN004947-4947 for Release: Wednesday, October 20, 1954 Hartnett Approves Care in Research [Committee to Be Sure That Reliable Evidence Is Available Before Announcing Important Conclusions to the Public About Smoking]
- CTRMN004948-4948 for Immediate Release (Thursday, October 21, 1954) Hartnett Comments on Cigarette Paper Burning [Timothy V. Hartnett Comments That A Cancer Causing Compound on Skin of Mice Has Been Produced by Burning Cigarette Paper Under Certain Lab Conditions]
- CTRMN004949-4952 for Release: A.M.'s, Monday, November 8, 1954 Tobacco Industry Research Committee Announces Initial Grants [Six Scientific Research Grants Totalling Over $82,000 Made Public]
- CTRMN004953-4954 for Release in A.M.'s, Monday, December 6, 1954 Scientific Associate Named by Tobacco Research Group [Robert C. Hockett Appointed As Scientific Director of TIRC to Help Develop Research Into Tobacco Use and Health]
- CTRMN004955-4956 for Immediate Release Cross-Country Lung Study Planned by Tobacco Group [Group of Pathologists Plan A Cooperative Study to Increase Knowledge of Lung Ailments]
- CTRMN004957-4959 for Release in Year-End Editions But Not Before December 27, 1954 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [TIRC Will Approve A Quarter of A Million Dollars for Research Into Public Health Problems by the End of 1954]
- CTRMN004960-4963 for Release: Monday A.M.'s, January 17, 1955 Tobacco Industry's New Research Grants Send Total to More Than $300,000 [New Research Grants Announced by TIRC to Relate to Both Human and Animal Scientific Studies]
- CTRMN004964-4966 for Release in A.M.'s of Friday, April 8, 1955 Tobacco Industry Group Votes Medical Research Fellowships [TIRC Announced Fellowship Program to Create Interest in Research Among Medical School Students]
- CTRMN004967-4969 Release Tuesday, May 17, 1955 and Thereafter Tobacco and Health Studies Cover Wide Range of Research [Although No Scientific Proof That Cigarettes or Air Pollution Cause Lung Cancer, Progress Is Being Made to Learn More About Tobacco Use and Health by the TIRC]
- CTRMN004970-4972 Tobacco Research Grants Increased to 490,000 Mark [Research Grants Are Created So Science Can Provide An Answer to Public Health Problems]
- CTRMN004973-4973 Hartnett Comments on Auerbach Paper [Many Studies on Human Lung Tissue, Not Enough Data Available to Draw A Conclusion Yet]
- CTRMN004974-4975 Anti-Smoking Theories Not Based on Complete Scientific Knowledge [Scientific Investigation Into What the Real Effects Are From Tobacco Use]
- CTRMN004976-4977 Hartnett Comments on Statistical Study [Research Intensified in Past Year, No Proof That Smoking Causes Cancer]
- CTRMN004978-4980 Doctor's Survey Termed 'biased, 'says Hartnett [Questionnaire Would Give No Concrete Conclusions About Tobacco Causing Cancer]
- CTRMN004981-4982 Hartnett Alerts Burley Men to Challenge Tobacco Attacks [Doctors Are Expressing Their Doubts About Statements Already Made; Tobacco Effects]
- CTRMN004983-4984 Bright Belt Warehouse Men Told Facts Challenge Critics [Still Looking for Proof That Tobacco Causes Cancer]
- CTRMN004985-4986 Tobacco Spokesman Says Facts and Position Are Unchanged [Various Experiments with Animals Showed That Cancer Was Not the Outcome From Tobacco Smoke]
- CTRMN004987-4987 Hartnett Comments on Statistical Study [Methods Used for Cancer Research Still Do Not Give Enough Information]
- CTRMN004988-4990 British Tobacco Experiments Unable to Induce Cancers [Still No Connection, Tests Will Continue]
- CTRMN004991-4993 Tobacco Research Grants Now Over 838,000 Mark [Tobacco Research Is Getting More Support From Doctors, Scientists, and Educators]
- CTRMN004994-4996 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Summary of the Past Years' Events in Tobacco Research]
- CTRMN004997-4999 Tobacco Research Fund Raised to 1,500,000 [Finding New Ways to Break Down Tobacco]
- CTRMN005000-5001 Tobacco Industry Group Renews Medical Research Fellowships [More Medical Students Are Receiving Fellowships Than Last Year]
- CTRMN005002-5003 Hartnett Statement on Cancer Meeting Reports [There Is Still Much Research to Be Done Before Tobacco Is Linked to Cancer]
- CTRMN005004-5005 [Pathologists From Around the Country Have Studied Human Lung Tissues Over the Past Year]
- CTRMN005006-5006 [Smoking Patterns Do Not Explain Differences in Lung Cancer]
- CTRMN005007-5008 Hartnett Cites British Tobacco Tests Failing to Produce Animal Cancer [the Search for Cancer Must Be Broadened and Intensified]
- CTRMN005009-5010 Hartnett Comments on Statistical Claims [Although Many Believe Smoking Causes Cancer, Scientists Still Have Not Found Any Prof]
- CTRMN005011-5011 [Present Knowledge Doesn't Hint A Relationship Between Smoking and Heart Problems]
- CTRMN005012-5016 Hartnett Comments on Cancer Society Booklet [Pamphlet Omits Some Important Research Results]
- CTRMN005017-5018 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Research Committee Needs More Scientific Investigation]
- CTRMN005019-5025 Tobacco Research Funds Reach 2.2 Million Mark [Over 60 Independent Scientists Throughout the Country Are Working in Institutions to Further the Research of Cancer and Tobacco Use, They Are Listed]
- CTRMN005026-5027 Hartnett Comments on French Report [French Are Reporting Rapid Cancer Formation in Mice, Hartnett Feels It Can't Be Judged on the Basis of New Reports Without Longer Consideration and Careful Analysis]
- CTRMN005028-5030 Harnett Cites Points for Clarification in Tobacco Health Study [Smoking Study Reached the Public's Attention Before It Was Reviewed and Before the Facts Were Made Crystal Clear]
- CTRMN005031-5032 Hartnett Comments on Wynder News Stories [News Story Claims That Assumptions Have Been Made About Mouse Skin Painting Experiments]
- CTRMN005033-5037 Statement on Smoking and Health Studies [Scientists Are Developing A Program for Different Phases of Tobacco Use and Health, Members Listed]
- CTRMN005038-5045 Hartnett Says Statistics Do Not Establish Causes [Studies Are Open to Assumptions and Certain Selection of Subjects]
- CTRMN005046-5048 Hartnett Cites Scientists Doubting Smoking-Cancer Theory [the Surgeon General Believes the Studies Are Missing Essential Facts That Should Be Acknowledged]
- CTRMN005049-5050 Scientist Comments on Benzpyrene Report [Benzpyrane in Tobacco Smoke, Under Investigation for Years Caused Cancer in Lab Animals But Not Humans]
- CTRMN005051-5055 "Cancer Researcher Challenges "Cause and Effect" Charges Against Smoking" [It's Difficult to Have A Cause and Effect Relationship When Dealing with Cancer and Tobacco Use]
- CTRMN005056-5056 [Atlantic Monthly Gives A Misleading Picture of Dr. Little and His Public Position]
- CTRMN005057-5058 Tobacco Committee Chairman Comments on Cancer Society Talk [Many Unresolved Questions About Tobacco Causing Cancer Don't Stop Researching]
- CTRMN005059-5061 Tobacco Research Scientist Discusses Smoking Question [Most Tend to Believe the Anti-Cigarette Theory But It Shouldn't Be Confused with the Facts There's Still Not Enough Facts to Prove That Smoking Causes Cancer]
- CTRMN005062-5062 Hartnett Says Leaflet Admits Differing Opinions on Smoking [Leaflet Tells How Scientists Disagree on Evidence]
- CTRMN005063-5066 Research Program Throws Doubts on Smoking Charges [Incorrect Claims and Harmful Effects From Tobacco]
- CTRMN005067-5069 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [More and More Scientists Had Doubts and Disbeliefs in the Charges Against Smoking As A Cause of Cancer]
- CTRMN005070-5071 Tobacco Research Scientist Discusses Smoking Question [Scientists Say Smoking Has Been Proved Guilty When Linked with Human Health Problems]
- CTRMN005072-5072 Pamphlet Merely Review, Dr. Little Says [Opinions Is All the Author Gives in His Pamphlet Scientists Are Still Disputing]
- CTRMN005073-5076 TIRC Fund for Research Boosted to $2,700,000 [Grants for Independent Scientists Interested in Studying Problems of Cancer and Heart Disease When Related to Smoking]
- CTRMN005077-5080 [New Knowledge on Smoking and Health Questions]
- CTRMN005081-5081 [Veterans Study of Smoking Habits]
- CTRMN005082-5082 [Report on How There Was Existing Research Evidence and How It Was Ignored]
- CTRMN005083-5085 [Regarding Anti-Tobacco Movement]
- CTRMN005086-5086 [Benzpyrene in Cigarette Smoke]
- CTRMN005087-5088 [Experimental Evidence Is Weak]
- CTRMN005089-5089 Hartnett Says Article on Arsenic Goes Beyond Facts [Farmers Use of Insecticides with Arsenicals on Growing Tobacco Has Steadily Been Declining]
- CTRMN005090-5091 [Scientists Who Produce Conflicting Results Are Being Ignored by the Health Department]
- CTRMN005092-5094 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Even More Grants Have Been Made Available More Factors Have Been Associated with Lung Cancer]
- CTRMN005095-5100 Tobacco Industry Group Announces Research Grants [Grant Increases to $3,200,000 List of Grants Announced]
- CTRMN005101-5103 Tobacco-Health Research Described in 1958 Report [the Report Talked About Experiments That Were Unable to Produce Cancer and the Cause and Effect Theory]
- CTRMN005104-5104 [Report Shows That Other Factors Besides Smoking Have Been Causing Lung Cancer, But Scientists Do Not Dismiss the Fact That Lung Cancer Is Possibility From Smoking]
- CTRMN005105-5105 [Anti-Smoking Campaign Is Thought to Be A One-Sided Propaganda Effort]
- CTRMN005106-5106 [Questions Arise From on-Sided Study]
- CTRMN005107-5111 Cancer Scientist's Comments on Smoking-Lung Cancer Review [Evidence on Smoking and Lung Cancer Is Accumulating, Among Other Contributing Factors]
- CTRMN005112-5117 [Comments Relating to Observation on Various Studies]
- CTRMN005118-5122 Research Grants Announced by Tobacco Industry Group [$500,000 Was Added to Research Funds, A List of Recipients with the New Grants Is Mentioned]
- CTRMN005123-5127 Research Supported by Tobacco Committee Discussed in Scientific Director's Report [It Seems That Finding An Answer to Lung Cancer and Cardiovascular Diseases Are Too Complicated]
- CTRMN005128-5128 [Attacks on Tobacco, the Lung Cancer Issue Is Still Not Settled]
- CTRMN005129-5129 Nta Stand on Smoking Repeats Opinions [Statement Gives No Evidence and Is Dealing Mainly with Opinions]
- CTRMN005130-5132 Tobacco Research Group Adds New Scientific Associate [New Scientific Director Was Added to the TIRC, Curriculum of J. Morrison Brady]
- CTRMN005133-5134 Tobacco Research Group Cites Questions Raised in Heart Statement [Lack of Evidence Proposes New Questions and Doubts About Cardiovascular Disease]
- CTRMN005135-5137 New Evidence Shows Complexities of Lung Cancer, Scientist Says [Hundreds of Studies Indicate Many Factors Contribute to the Complex Chain That May Result in Lung Cancer, No One Can Figure Out the Right Factor and Still the Reported Lung Cancer Cases Are Rising]
- CTRMN005138-5140 New Grants to Scientists Made by Tobacco Research Group [Research Grants Totalling $523,000 Made to 40 Scientists This Year]
- CTRMN005141-5144 Cancer Research Opens Up New Areas, Extra Funds Appropriated for Study [TIRC Stepping Up Financial Support of Independent Health Research]
- CTRMN005145-5147 Scientists in 11 States Get Research Grants for Tobacco-Health Studies [17 Research Grants Totaling Nearly $200,00 Awarded to Scientists in 11 States for Studies of Tobacco Use and Health]
- CTRMN005148-5151 New Direction for Tobacco-Health Research in '61, Says Chairman of Tobacco Industry Research Committee [Future Research to Concentrate on How Lung Cancer and Heart Disease Originate]
- CTRMN005152-5160 Research on Smoking and Health Discussed by Scientific Advisory Board to T.I.R.C. [Health Research Expansion Called for in 22 Specific Areas]
- CTRMN005161-5162 Scientist Reports on Research Progress As T.I.R.C. Boosts Funds to $4,650,000 [Dr. Clarence Cook Little Proposed Steps for Medical Research]
- CTRMN005163-5163 Nation's Medical Students Offered Research Fellowships by Tobacco Research Group [Program Designed to Encourage Research As A Career]
- CTRMN005164-5168 Scientists in 14 States Get Research Grants for Tobacco-Health Studies [Fifteen Grants for New Research Announced]
- CTRMN005169-5173 Tobacco Industry Research Committee Adds $800,000 for New Research [Emphasis Put on Viruses, Bioassay, Psychological and Physiological Research]
- CTRMN005174-5176 ""Significant Developments" in Cancer Research Reviewed in Annual Report by Dr. C.C. Little" [Scientific Findings of the Past Year Reviewed]
- CTRMN005177-5179 Tobacco Research Group Offers Fellowships to Medical Students to Spur Interest in Research Work [Program Designed to Encourage Career in Research]
- CTRMN005180-5180 Tobacco Research Committee Chairman Comments on Mouse Skin Painting [Harmless Everyday Substances Can Cause Cancer in Laboratory Animals]
- CTRMN005181-5182 Smoking-Health Situation Calls for Facts, Not Emotions, Says Hartnett [Repetition Does Not Add to Scientific Knowledge]
- CTRMN005183-5217 Smoking-Health Situation Calls for Facts, Not Emotions, Says Hartnett [Repetition Does Not Add to Scientific Knowledge]
- CTRMN005218-5224 52 Additional Research Grants Made by Tobacco Industry Group [Money for Studies Designed to Give New Leads to Lung Cancer and Other Health Problems]
- CTRMN005225-5225 Medical Student Fellowships Offered by Tobacco Research Group [Program to Encourage Research]
- CTRMN005226-5228 Gaps Still Exist in Knowledge of Lung Cancer and Heart Disease, Says Little [Multiple Factors and Influences That Contribute to Lung Cancer Unknown]
- CTRMN005229-5230 Scientific Director of Tobacco Industry Research Committee Comment on Resolution by American Heart Association [TIRC Welcomes Recognition of Need for Further Research to Determine Full Facts About Smoking]
- CTRMN005231-5234 Tobacco Committee Adds $1 Million for Continuing Research Studies [Scientific Advisory Board Assured TIRC Will Provide More Funds]
- CTRMN005235-5235 [Scientific Director of TIRC Sent Telegrams to the Surgeon General and the President of the Ama]
- CTRMN005236-5236 [Ama Supports Research on Tobacco and Health]
- CTRMN005237-5239 [TIRC Renamed and Reorganized]
- CTRMN005240-5241 Dr. Howard B. Andervont Named to the Scientific Advisory Board [Editor of the Journal of the National Cancer Institute Appointed]
- CTRMN005242-5277 Tobacco Industry Group Awards $817,165 for Health Research [37 Additional Research Grants Have Been Awarded by the Ctr]
- CTRMN005278-5282 Scientific Director C.C. Little Reports Decade of Tobacco-Health Research [Findings on What Diseases Smoking Can Cause]
- CTRMN005283-5286 Council Awards $500,000 for Tobacco and Health Research [Number of Grants Awarded for Tobacco Use and Health Research]
- CTRMN005287-5291 Summary of the Testimony of Clarence C. Little Before the Senate Commerce Committee [Discussion on Cancer and How It Affects Our Bodies]
- CTRMN005292-5319 Council Awards $514,767 for Tobacco and Health Research [Number of Grants Awarded to Scientist Over the Period of 10 Years]
- CTRMN005320-5348 Tobacco - Health Studies Reviewed in Annual Report [Discussion on Cigarette Smoking Being Helpful with Causing Diseases in Smokers]
- CTRMN005349-5367 Tobacco and Health Research Awards Pass $9 Million Total [Grants Given to Scientist Studying Matter Related to Tobacco Use and Health]
- CTRMN005368-5375 Tobacco-Health Research Grants Awarded New York Scientists [Scientists Approved to Continue Research on Lung Cancer and Other Diseases]
- CTRMN005376-5382 Tobacco - Health Studies Reviewed in Annual Report [Studies of the Respiratory System in Experimental Animals and Human Patients Especially on Causes of Pulmonary Cancers]
- CTRMN005383-5384 [Opinions of Scientists That There Is No Relationship Between Smoking and Disease]
- CTRMN005385-5387 New Tobacco-Health Research Grants Total $2 Million [Number of Approved Grants for Studies on Tobacco Use and Health]
- CTRMN005388-5388 Furst Becomes Consultant to Tobacco Research Council [Dr. Furst Advise to Council on Programs Sponsored by Them]
- CTRMN005389-5393 Studies Raise Questions About Smoking As Health Hazard [Numerous Studies Done to Show What Effect Smoking Had on Our Health]
- CTRMN005394-5400 Broad Review of Tobacco-Health Picture Covered in Dr. Little's Latest Report Lung Cancer, Heart Disease, Chronic Pulmonary Ailments Are Complex in Nature, Says Noted Researcher Genetic and Environmental Factors May Be Involved Reports Scientific Director of Council for Tobacco Research [Recent Research Finding on Lung Cancer, Heart Disease and Chronic Pulmonary Ailments]
- CTRMN005401-5404 Significant Smoking-Health Finding Covered in Report by Dr. C.C. Little [Findings From Independent Scientists on Smoking and Health]
- CTRMN005405-5408 New Tobacco-Health Grants Announced; One Helps Revive Framinghan Heart Study [Awards Granted to Independent Scientists Researching Tobacco and Health]
- CTRMN005409-5412 New Scientific Findings About Cancer, Heart Disease, the Lung, Other Areas, Reported by Council for Tobacco Research [New Findings From Independent Scientists Relating to Tobacco and Health Issue]
- CTRMN005413-5415 New Smoking-Health Studies Boost Total to $23-Million [Council Awards More Grants to the Study of Lung Cancer, Viruses and Cancer, Heart Disease, and Chronic Pulmonary Ailments]
- CTRMN005416-5418 Progress in Tobacco-Health Research Achieved: Machines That Simulate Human Smoking [Machines to Help Scientists Effectively Study Smoke and Health Issues]
- CTRMN005419-5421 Noted Cancer Scientist Named Scientific Director of the Council for Tobacco Research [Dr. Hockett Who Was Acting Scientific Director Got Promoted to Research Director]
- CTRMN005422-5425 Massive Cancer Study Using Made-to-Order Mice [Study Using Mice to See If Human Lung Cancer Can Be Induced Regularly]
- CTRMN005426-5427 Tobacco Research Group Announces New Studies [12 New Studies Have Been Funded to Study Generic Factors in Lung Cancer and Emphysema and the Possible Influence of Nicotine on Fetal Growth]
- CTRMN005428-5429 Studies of Twins Expanded by Tobacco Research Group [Human Twins Used for Study to Determine Effects of Environment Agents on Various Diseases]
- CTRMN005430-5432 News About Smoking and Health Study Interaction of Genetic and External Influences in Lung Cancer [Studies Show That Only Minority of Smokers Get Lung Cancer Therefore Lung Cancer May Be Caused by Genetic Characteristics or External Influences Which People Have Been Exposed]
- CTRMN005433-5434 New Smoking and Health Grants Made by Tobacco Research Council [New Studies Have Received Grants to Continue Researching on Smoking and Health]
- CTRMN005435-5435 Yeaman Assumes Leadership of Council for Tobacco Research [Addison Yeaman Succeeds H.H. Ramm for Chairman and President of the Council for Tobacco Research]
- CTRMN005436-5438 14 New Studies Funded by Tobacco Research Council [Grants Awarded to Studies for Inhibition of Cancer by Different Chemicals, the Influence of Nicotine on Pregnancy and the Effects of Cigarette Smoke on the Body's Disease Fighting System]
- CTRMN005439-5441 Progress Being Made in Research on Emphysema [Scientist Discover Ways to Help Defend Against Emphysema]
- CTRMN005442-5444 14 New Smoking-Health Projects Are Approved [Recent Research Studies Dealing with Smoking and Health Have Been Given Grants]
- CTRMN005445-5446 Grants Awarded for New Smiking-Health Studies [Scientists Were Approved for Studying of Certain Enzymes in Human Lung Cancer and Emphysema]
- CTRMN005447-5448 Tobacco Research Report Discusses Heart Disease [Studies Have Found Progressive Atherosclerosis Rank First As Number One As Causes of Death From Cardiovascular Disease]
- CTRMN005449-5451 Grants Awarded for New Smoking-Health Research [New Studies Have Been Approved for Marker Substance That May Indicate Presence of Lung Cancer and on Smoking and Pregnancy]
- CTRMN005452-5453 Tobacco Research Group Funds New Smoking-Health Projects [A New Study for Relationship of Childhood Respiratory Disease to the Development of Adult Chronic Lung Disease]
- CTRMN005454-5455 Tobacco Research Group Reports... Funds for Smoking-Health Studies Pass $46,000,000 [Amount Council Has Given to Scientist for Research]
- CTRMN005456-5458 $5.9 Millions Given for Smoking-Healths Studies [Council Has Given Millions Over the Years to Researchers]
- CTRMN005459-5460 Tobacco Research Group Says... Continued Research Needed to Find Causes of Cancer and Other Major Diseases [Council Pledges to Continue to Give Financial Support to Scientists Studying Smoke-Health Issues]
- CTRMN005461-5462 $6 Million Granted for Smoking-Health Studies [Millions Given to Scientist for Further Study]
- CTRMN005463-5465 Tobacco Research Group Continues Funding for Independent Scientists [Council Has Provided Millions Over the Years to Researchers and Will Continue to Do So]
- CTRMN005466-5467 $5.5 Million Given for Smokin-Health Studies [Council Has Given Millions to New and on Going Studies Over the Years]
- CTRMN005468-5469 Annual Report Issued by Tobacco Research Group [Over 1.5882 Reports From Scientists Acknowledging Support From the Council Have Been Published]
- CTRMN005470-5473 $6 Million Awarded for 34 New Smoking-Health Studies [Millions Were Given to Scientists with New Studies and Continuing Ones From the Council]
- CTRMN005474-5474 Ctr's Latest Report Sets Abstract Record [More Reports Were Published From Scientists Acknowledgingg Support From Council for Tobacco Research Than Any Other Report Published in the Past]
- CTRMN005475-5475 Scientists Show... Growing Interest in Doing Smoking and Health Studies [Growing Number of Application Have Gone to the Council of Tobacco Research for Funding on Smoke Related Diseases]
- CTRMN005476-5479 $7 and A Half -Million Awarded for Smoking-Health Research [Millions Given to Scientists for Studying Lung Disease]
- CTRMN005480-5481 Council for Tobacco Research Announces... Hoyt and Hockett Retire After 30 Years: Gertenbach Is Named New President [Introduction to President of the Council for Tobacco Research]
- CTRMN005482-5482 Ctr's Annual Report Sets Abstract Record [the Number of Reports Acknowledging Support by the Council of Tobacco Research Is More Today Than It Was Years Ago]
- CTRMN005483-5485 Findings Published on Cigarette Smoke Inhalation Study with Mice [Results From Study Show That Smoke Did Not Produce Any Squamous Cell Lung Cancer]
- CTRMN005486-5525 Statement of Dr. Clarence Cook Little, Scientific Director, Tobacco Industry Research Committee, at Press Conference, University Club, New York City, June 15, 1954 [Regarding Relationship Between Lung Cancer and Tobacco]
- CTRMN005526-5533 "Transcript of Edward R. Murrow's First Tv Show on "Cigarettes and Lung Cancer"" [Regarding Experiments That Show That Cigarette Smoking Increases Chances for Lung Cancer]
- CTRMN005534-5541 "Transcript of Edward R. Murrow's Second Tv Show on "Cigarettes and Lung Cancer"" [Regarding Issue That Cigarette Smoke Does Not Cause Lung Cancer]
- CTRMN005542-5562 the Lung Cancer Problem and the Research Program of the Tobacco Industry Research Committee [Regarding Continuation of Study Dealing with Tobacco and Health]
- CTRMN005563-5573 A Report of Progress [Results From the Study of Smoking and Health Issue Will Greatly Depend on Well Planned and Well-Executed Scientific Research]
- CTRMN005574-5585 Tobacco and the Cardiovascular System the Program of the Tobacco Industry Research Committee [Program Strives to Discover Facts and Relationships Described with Objectivity]
- CTRMN005586-5597 A Search for Facts [Regarding Information Needed to Be Gathered on Smoking and Health Problems to Defend Industry]
- CTRMN005598-5605 the Lung Cancer Problem and the Research Program of the Tobacco Industry Research Committee [Discussion on Different Studies Will Continue to Be Made Until A Answer Is Found]
- CTRMN005606-5607 Cancer Research Guest Editorial Smoking and Lung Cancer Volume 16 [St Regarding Support Given to Scientist for Research]
- CTRMN005608A-5609 "Correspondence Regarding "Smoking and Health"" [Discussion on Researching on Tobacco and Health with Objectivity and Not Be Judgmental]
- CTRMN005608B-5609 Hypfibrinogenemia [Regarding Transfusions and Clotting Mechanism in A Case of Extraordinarily Delayed Post-Partum Hemorrhage]
- CTRMN005608C-5609 Diabetic Children [Admitting Omission of Different Data From Other Sources]
- CTRMN005608D-5609 Revocation of Licenses [Revoking of Registration From Dr. Louis A. Scinta]
- CTRMN005610A-5613 Mayo Clinic Head Believes Smoking Not Cancer Cause Tobacco and Health Volume 1 Number 1 [Smoking Not Believed to Be Cause of Lung Cancer, According to Some Noted Physicians]
- CTRMN005610B-5613 Six Experts State Doubts on Smoking-Cancer Theory Tell Congressmen Reasons for Position Tobacco and Health Volume 1 Number 1 [Reasons for Not Accepting Theory That Smoking Causes Lung Cancer]
- CTRMN005610C-5613 New Book Says Tobacco 'scare' Not Justified Tobacco and Health Volume 1 Number 1 [""Science Looks at Smoking"]
- CTRMN005610D-5613 Editors View Smoking-Cancer Tie As Unproved, Open Question Excerpts From Editorials Tobacco and Health Volume 1 Number 1 [Excessive Smoking Probably the Main Cause of Lung Cancer, While Moderate Smoking As Causation of Lung Cancer Has No Scientific Support]
- CTRMN005610E-5613 British Scientist Opposes Campaign Against Smoking Tobacco and Health Volume 1 Number 1 [Sir Ronald Fisher, British Statistician, Refuses to Produce Anti-Smoking Writing, States It As A Cause for Anxiety]
- CTRMN005610F-5613 'pick Your Expert, Take Your Choice' Tobacco and Health Volume 1 Number 1 [Witnesses Linking Cigarettes to Lung Cancer Testify Before House Operations Sub-Committee]
- CTRMN005610G-5613 'still Open Question' Tobacco and Health Volume 1 Number 1 [Authorities on Cancer State That Smoking Is Not Proven to Cause Lung Cancer]
- CTRMN005610H-5613 Smoking and Death Rates Tobacco and Health Volume 1 Number 1 [If Everyone Stopped Smoking There Would Be No Significant Change in Death Rate]
- CTRMN005614-5616 Summary of Comments for Delivery Before: Central Subsection, North Jersey Section, American Chemical Society, Elizabeth, New Jersey [Review of the Chemical Analysis of Cigarette Smoke and Investigations of Smoking and Lung Cancer]
- CTRMN005617-5620 the Public and Smoking Fear or Calm Deliberation? [How Doubt, Suspicion and Fear May Affect the Deliberation of Whether Cigarette Smoking Causes Lung Cancer or Other Ailments]
- CTRMN005621A-5624 TIRC Reports Progress in Smoking-Health Research Tobacco and Health Volume 1 Number 2 [Too Many Unknowns Exist Concerning Lung Cancer to Warrant Conclusions Citing Smoking As Causation of Lung Cancer]
- CTRMN005621B-5624 'tar' Misnomer for Condensed Smoke Tobacco and Health Volume 1 Number 2 [Difficulties in Analyzing Tobacco Smoke Make Tobacco Tar A Misnomer]
- CTRMN005621C-5624 New Statistics Contradict Anticigarette Theory Tobacco and Health Volume 1 Number 2 [Cigarette Smoking May Be Compatible with Normal Health Report on Done Smokers Who Have Longer That Average Life Span]
- CTRMN005621D-5624 TIRC Funds for Smoking Research Now Over $2,000,000 Tobacco and Health Volume 1 Number 2 [Scientific Advisory Board Approves 52 Grants and Renewals in 1957 Totalling $550,000]
- CTRMN005621E-5624 Press Questions Anti-Smoking Plan Tobacco and Health Volume 1 Number 2 [State-Supported Campaign Against Cigarettes Warranted in New York]
- CTRMN005621F-5624 Study Suggests Bronchitis May Be Prime Factor in Lung Cancer Tobacco and Health Volume 1 Number 2 [Preliminary Study at Beatty Institute Favors Bronchitis As A Factor of Lung Cancer]
- CTRMN005621G-5624 Doctors' Comments on Smoking-Health Tobacco and Health Volume 1 Number 2 [Increasing Number of New Chemicals in the Atmosphere at Fault for Rise in Cancer]
- CTRMN005621H-5624 Nation-Wide Lung Tissue Study Now Being Evaluated Tobacco and Health Volume 1 Number 2 [TIRC Studying Lung Tissues From 1,600 Persons]
- CTRMN005625-5648 Biological Aspects of Cancer Research Journal of the National Cancer Institute Vol. 30, No. 3 [St Background Research and New Information on Cancer Studies]
- CTRMN005649-5654 Interview the Cigaret Smoker and Lung Cancer Reprinted From Modern Medicine, Vol 26 [St Advises on Smoking and Its Relation to Health]
- CTRMN005655-5660 Comments on the Mortality of Smokers and Non-Smokers. A Paper by Harold W. Dorn Before the American Statistical Association Dec. 27, 1958 [Reflections on Figures Presented in Dorn's Paper]
- CTRMN005661-5671 An Experimentalist Looks at Statistics on Smoking [Reflections on the Figures in Dorn's Paper]
- CTRMN005672-5672 Letters to the Times Findings on Smoking [Statistical Proof of Link Between Smoking and Cancer Denied]
- CTRMN005673-5683 A Brief Review of the Smoking-Lung Cancer Theory [Review of Data Known on the Relation Between Cigarette Smoking and Lung Cancer]
- CTRMN005684-5686 Cancer-the Research Approach [Discussion on Cancer and A Category of Factors Which May Play Roles in Cause and Development of Cancer]
- CTRMN005687-5692 [Address Before the Burley and Dark Leaf Tobacco Export Association, Inc. Information About the Research Program Supported by the TIRC]
- CTRMN005693-5697 Some Phases of the Problem of Smoking and Lung Cancer the New England Journal of Medicine Vol. 264 No. 24 [St Disputes Findings That Smoking Causes Lung Cancer]
- CTRMN005698-5704 Some Aspects of the Lung Cancer Problem Reprinted From Punjab Medical Journal Vol. Xi No. 7 [St Discussion of Relationship of Cigarette Smoking to Lung Cancer]
- CTRMN005705-5735 Current Knowledge of Tobacco and Health [Discussion of Experimental Attack on Lung Cancer and Tobacco Use]
- CTRMN005736-5739 Cigarettes-Why More Research? Reprinted From the Yale Scientific Magazine [St Comments on the Uncertainties of the Correlations Between Cigarette Smoking and Lung Cancer]
- CTRMN005740-5740 Why Do People Think That Quitting Smoking Affects Their Appetite or Their Weight? the Apothecary [St Comments on the Scientific Basis of How Smoking Affects Hunger]
- CTRMN005741-5754 Address to Be Delivered by Dr. Clarence Cook Little, Scientific Director, the Council for Tobacco Research - U.S.A. At A Dinner Honoring the Centennial of the University of Kentucky and the Burley Tobacco Industry Lexington, Kentucky January 12, 1965 [Talk Addressing Research Programs of the University of Kentucky]
- CTRMN005755-5772 Communications and the Biological Sciences [Brief Discussion of Principles That Should Inspire and Guide Communications in the Biological Sciences]
- CTRMN005773-5785 Perspectives in the Experimental Approach to the Human Lung Cancer Problem [Experimental Research on Lung Tumors in Animals May Lead to Insights on Human Lung Cancer]
- CTRMN005786-5798 Tobacco and Health Research [Elaboration on the Purpose, Research Practices and Studies of the TIRC]
- CTRMN005799-5805 Tobacco and Health Research [Discussion of Experimental Studies by the TIRC Concerning Smoking and Health]
- CTRMN005806-5813 the Research Perspective on Smoking and Health [Discussion on the Search for Causes of Diseases with Which Smoking Has Been Associated]
- CTRMN005814-5820 Tobacco and Health Research [Discussion of Studies on Cigarettes and the Diseases Statistically Associated with Smoking]
- CTRMN005821-5834 Tobacco and Health Research - Where Shall We Go From Here? [Suggestions for Continuing Studies and Research on Cigarette Smoking and Health]
- CTRMN005835-5852 A Look Ahead Smoking and Health - Where Do We Stand? [Talk on Chronic Diseases and Factors of Their Causation and Development in Relation to Cigarette Smoking]
- CTRMN005853-5854 Smoking-Disease Links Continue to Lack Scientific Proof [Discusses the Role of the Council for Tobacco Research]
- CTRMN005854-5854 Lawrence Promoted to Vp Post at Mmi [Jack Riddle Announces the New Vp of Micro-Magnetic Industries]
- CTRMN005854A-5854 Philip Morris Expands Promotional Allowances [Discusses Special Offers Made to Philip Morris Vendors]
- CTRMN005855-5882 Chapter 3 the Tobacco Health Issue: An Overview of Medical Research [St Questions Methodology of Experiments Where the Sole Objective Was the Attempt to Induce Tumors]
- CTRMN005883-5900 the Research Program (Cancer Segment) of the Council for Tobacco Research - U.S.A., Inc. Presentation Before the Tobacco Working Group [Describes the Concept, Plan, and Purpose of the Council for Tobacco Research]
- CTRMN005901-5902 Smoking Prevention Education Act Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Eighth Congress First Session on H.R. 1824 [Statement of Sheldon C. Sommers]
- CTRMN005903-5919 [Regarding Anti-Smoking Bill]
- CTRMN005920-5931 Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Eighth Congress First Session on H.R. 1824 March 9 and 17, 1983 Serial No. 98-8 Statement of Robert Casad Hockett Regarding H.R. 1824 [Disputes Findings Set Forth in H.R. 1824 Regarding Cancer, Cardiovascular Disease, Atherosclerosis and Emphysema]
- CTRMN005932-5932 Hearings Before the Committee on Labor and Human Resources United States Senate Ninety-Eighth Congress First Session on S. 772 May 5 and 12, 1983 [Concerning Smoking Prevention Health and Education Act of 1983]
- CTRMN005933-5940 Statement of Sheldon C. Sommers, M.D., Consultant in Pathology, Lenox Hill Hospital, New York, N.Y. [Comments on Smoking Prevention Health and Education Act]
- CTRMN005941-5963 Hearings Before the Committee on Labor and Human Resources United States Senate Ninety-Eighth Congress First Session on S. 772 to Promote Public Health by Improving Public Awareness of the Health Consequences of Smoking and to Increase the Effectiveness of Federal Health Officials in Investigating and Communicating to the Public Necessary Health Information, and for Other Purposes Statement of Robert Casad Hockett Regarding S. 772 [Disputes Methodology of Experiments Which Expose Animals to Smoke]
- CTRMN005964-6009 Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Seventh Congress Second Session on H.R. 5653 and H.R. 4957 March 5, 11, and 12, 1982 Serial No. 97-106 [Disputes Methodology of Experiments to Demonstrate That Cigarette Smoking Can Cause Lung Cancer in Animals]
- CTRMN006010-6012 Testimony of Dr. Robert C. Hockett During Hearing on Cigarette Smoking and Health Before the Subcommittee on Oversight and Investigations of the House Committee on Interstate and Foreign Commerce, October 5, 1978 [Responds to Question Regarding Research on Health and Smoking]
- CTRMN006013-6023 Statement of Robert C. Hockett, Ph.D. Before the Subcommittee on Oversight and Investigation of the Committee on Interstate and Foreign Commerce in Response to the Letter Dated September 27, 1978 From the Chairman of the Subcommittee to William U. Gardner, Ph.D., Scientific Director, the Council for Tobacco Research - U.S.A., Inc [Discusses the Purpose of the Council for Tobacco Research]
- CTRMN006024-6069 Hearings Before the Subcommittee on Health of the Committee on Labor and Public Welfare United States Senate Ninety-Fourth Congress Second Session on S. 2902 February 19, March 24, and May 27, 1976 [Disputes Scientific Basis of S. 2902]
- CTRMN006070-6125 Hearings Before the Consumer Subcommittee of the Committee on Commerce United State Senate Ninety-Second Congress Second Session on S. 1454 Serial No. 92-82 [Discussion of Cigarette-Smoking and Peptic Ulcers]
- CTRMN006126-6135 Report of the Scientific Director [St]
- CTRMN006136-6189 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 February 1, 5, and 10, 1972 [Discusses Edimeological Comparisons Between Smokers and Non-Smokers]
- CTRMN006190-6200 [Bibliography Listing Over 1,275 Articles and Books About Tobacco and Disease]
- CTRMN006201-6311 [Articles About Tobacco and Disease]
- CTRMN006312-6321 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statement of Dr. Sheldon C. Sommers]
- CTRMN006322-6348 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statement of Dr. Robert Casad Hockett]
- CTRMN006349-6359 Hearings Before the Consumer Committee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statements of Dr. Sheldon C. Sommers and Dr. Robert C. Hockett]
- CTRMN006360-6370 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [References Reporting on Tobacco and Nicotine]
- CTRMN006371-6412 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Ninety-First Congress First Session on H.R. 643 A Bill to Amend the Federal Cigarette Labeling and Advertising Act with Respect to the Labeling of Packages of Cigarettes and for Other Purposes (and Similar Bills) [Statement of Dr. Sheldon C. Sommers]
- CTRMN006413-6492 Hearings Before the Committee on Commerce United States Senate Eighty-Ninth Congress First Session on S. 559 and S. 547 Bills to Regulate Labeling of Cigarettes and for Other Purposes [Statement of Dr. Clarence C. Little]
- CTRMN006493-6533 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug, and Cosmetic Act So to Make That Act Applicable to Smoking Products [Statement of the Council for Tobacco Research U.S.A. History and Organization]
- CTRMN006534-6540 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug and Cosmetic Act So As to Make That Act Applicable to Smoking Products [Statement of Clarence Cook Little, SC.D.]
- CTRMN006541-6548 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug, and Cosmetic Act So As to Make That Act Applicable to Smoking Products [Statement of Robert Casad Hockett, Ph.D.]
- CTRMN006549-6577 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Statement of Dr. Clarence Cook Little]
- CTRMN006578-6611 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Statement Concerning the Origin and Purpose of the Tobacco Industry Research Committee and Its Proposed Functions]
- CTRMN006612-6614 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Hartnett Cites Scientists Doubting Smoking-Cancer Theory]
- CTRMN006615-6618 Research Into Smoking and Health [Arguments Against Tobacco Cancer Link]
- CTRMN006619-6623 [Study to Examine Reported Causes of Death in Each of 17 Regions in Houston Specifically the Five Major Respiratory Diseases]
- CTRMN006624-6624 A Frank Statement to Cigarette Smokers [Industry Promotes Research Into Tobacco Disease Link]
- CTRMN006625-6625 the Council for Tobacco Research - U.S.A., Inc. Board of Directors [Members of the Board]
- CTRMN006626-6627 the Council for Tobacco Research - U.S.A., Inc. Scientific Advisory Board [Members of the Board]
- CTRMN006628-6634 No. E-121,486 I. D. Rogers, Individually and As Independent Executor of the Estate of Marjorie Helen Rogers, Deceased; Et Al Vs. R. J. Reynolds Tobacco Company, Et Al in the District Court of Jefferson County, Texas 172nd Judicial District Third Amended Notice of Intention to Take Oral Deposition [Matters on Which Ctr Witnesses Must Be Knowledgeable]
- CTRMN006635-6967 Deposition of Dr. James Glenn [Deposition of Glenn in the Matter of Broin]
- Author
- Ctr
- Request
- 118
- Type
- ANNUAL REPORT
- Box
- 002
- UCSF Legacy ID
- hnq30a00
Document Images
t-Xhl. ~f
J C~`
( ;'t 11;'hill t`t[4 ('..~(,)I 'ir"


SCIENTIFIC ADVISORY BOARD
to Thc Council for Tobacco Rcscarch-U.S.A., Inc.
as of December 31, 1975
SHELDON C. SOMMERS, M.D., Chairman
Director of Laboratories. Lenoz Hill Hospital
Clinical ProJessor of Pathology
College of Phyciciana & Surgeons of Columbia University
New York, New York
RICHARD M. BING, M.D.
Director of Cardiology and Intramural Medicine
Huntington Memorial Hospital, Paaadena, California
Professor of Medicine
University of Southern California School of Mcdicine
Los Angeles, California
JOSEPH D. FELDMAN, M.D.
Head, Department of Immunopathology
Scripps Clinie and Research Foundation
La Jolla, California
WILUAM U. GARDNER, PH.D.
ScientiJ'ic Direcmr, The Council for Tobacco Research-U.S.A., Inc.
E. K. Hunt ProJessor of Anatomy (emeritus)
Yale Univera+ty School of Modicine
New Haven, Connecticut
ROBERT J. HUEBNER, M.D.
Chie/, Laboratory of RNA Tumor Viruses
National Cancer Institute
Betheada, Maryland
LEON O. JACOBSON, MD.
Director, The Franklin McLean Memorial Research Institute
RegeRrtein Pro%aroi of Biological Sciences
University ol Chkayo
Chiu8o, ]llinoia
AVERILL A. LIEBOW, M.D.
ProJesaor and ChaLman, Department of Pathology
University of California School of Medicine
San Diego. Catifocnia
FUNRY T. LYNCH, M.D.
ProJesaor and Chdrmarr
Deparitment of Preventive Modkine and Public Health
Cie3 ton Unlverslty School of Medicine
Om.~a Nebcaaka
iIANS MEIER, D.V.M., Dr. Mcd. Vct., M.R.SJi.
Senior .StafJ Scientist
The Jackson Iatxxatory
Bar I larbor, Maine
LEE W. WA7TENBERG, M.D.
Professor of Pathology
Department of Laboratory Medicine and Pathology
University of Minnesota Medical School
Minneapolis, Minnesota
JOHN P. WYATT, M.D.
Director
Tobacco and Health Research Institute
Univcrsity of Kentucky
Lexington, Kentucky
Scientific Staff of The Couneil
WILLIAM U. GARDNER, Prt.D.
Scientific Director
ROBERT C. HOCKETT, Ptt.D.
Research Director
lfr
00.
1,-
JOHN H. KREISHER, Px.D. DAVID STONE, Ptt.D.
Associate Research Director .4ssociate Research Director
VINCENT F. LISANTI, D.M.D.
Research Associate

C
I
CONTENTS
Introduction . . - ' 5
Studics Related to Respiratory Function and
Chronic Pulmonary Diseases . .
. 7
Abstracts of Reports . . . . . . . . . . . . . . . 14
Canccr-Rclatcd Studies . . - - 14
The Respiratory System . . . 24
Heart and CSrculation . . . . . . . . . . . . . 35
Ncuropharmacology and Psychophysiology . . 47
Pharmacology . . . . . . . . . . . . . . . 53
Immunology and Adaptive Mcchanisms . . . . . . . 55
Epidemiology . . . . . . . . . . . . . . . 62
Active Projects . . . . . . . . . . . . . . . . . 66
Completed Projects . . . . . . . . . . . . . . . . 73
Indcx of Principal Investigators . . . . . . . . . . 83
Index of Senior Authors . . . . . . . . . . . . 84
Introduction
The Annual Report of 1973 had one of its seven sections devoted to the
presentation of some research on lung (unction nd chronic respiratory dis-
cases. During the past two years, studies on respiratory functions of man and
lahtuatory animals have advanced greatly. Sophisticated biochemical methods
have been used to study thc dcfcnsc mechanisms of the lungs, their response
to the internal environment as determined by the genetic background of the =
subject and their response to external stimuli. The abstracts of the investiptions
that have been supported during 1975 in this and in other research areas are [
included in the third section of this report. F.
The previous Annual Report emp hasized the researches that were relatcd (
to cancer and to the considerable effort that has been made to develop methods
for the delivery to, and retention of smoke or smoke components in, different
parts of the respiratory tracts of mice, the animals that had been selected for
the smoke exposure experiments.
This year's Annual Report emphasizes investigations that have been under-
taken on the respiratory system and on the epidemiology of respiratory dis-
eases. In some ways the classification is somewhat arbitrary. For example, em-
physema might be considered under the respiratory system, but because many
studies on this disease involve hereditary and environmental components, certain
studies might be classified under epidemiology. The rapid development in these
areas during the last few yean led The Council to convene a two-day informal
conference during 1975 at which a number of inveatitators concerned with the
lung's protein-dcstroying enzymes and their inhibitors had an opportunity to
communicate and compare their most recent investigations. The subjects dis-
cussed in detail are presented in the following section of this report.
Identical twins, like laboratory animals of highly inbred strains, provide
the best means of determining the impact of the environment on the senotype.
When environmental factors are discordant the expression of the genotype may
be modified. The New Swedish Twin Registry - twins born in Sweden from
1926 to 1959 - has been completed with some 32,000 entries of like-sexed
twins. A Finnish Twin Registry has been compiled and much information is
being obtained through responses to questionnaires. The contrasting incidences
of pulmonary cancer and coronary heart disease in Sweden and in Finland
should add significance to the data that may be derived from studies of these
registries. The studies will involve not only the identical and the noo-ideoticat,
like-sexed twins, but also the twins as individuals making up a erou section
of the populations.
Pulmonary function of populations at different ages and different areas of
residcnce and diRcrent occupations hu been determined and the dfeets of
familial or hereditary inftucnces have been deseribed and diacussed.
New observations have also been made on lung structure; neuroepithelial
bodies have been found in the human lungs and described in detail. Their
(unction is not known with certainty. They probabty contribute to the normal
function of the lung. Even at this time, new structures and potential regulatory
mechanisms of lungs, which provide that narrow interface between environ-
ment and blood, can still be discovered
The following review of the stud'w related to respiratory functios and
chronic pulmonary diseases reveals the interests of The Couacil in these areas
5

of research. Bccaux o( concern with human well-being. studics arc being danc
with human subjccts when possible. Epidemiological studies cspccially must
relate to human populations. In other studies, animal models must hc u.ed to
reveal information to augment our knowledge of Ihe etiology and pathogencsis
of those aging-associated diseascs of the pulmonary and cardiovascular systems.
WILLIAM U. GARDNLR, PII.D.
Scientific Director
` '-
~ J
i._..
Studies Related to
Respiratory Function and
Chronic Pulmonary Diseases
®
.
The Council's 1973 Report presented general concepts and plans underly~
ing the rescarch program in respiratory function and disease. Along these linet-
a doren projects in a number of research institutes were maintained during &4,)
year just ended, with collateral support by contract studies for equipment de-
velopment and methodology.
i1 nimal Studies Involving /nhalation Exposures
In four studies animals were exposed chronically, by inhalation, to agents
widely present in human environments.
One investigator, who had developed methods for measuring pulmonary
functions in mice, subjected animals of two strains to cigarette snake inhalation
daily for five to ten weeks. High- and low-niootine reference cigarettes were
used to compare the effects of different nicotine kveis in smokes otherwise very
similar. Effects of whole, fresh smoke inhalation were similarly compared with
those of the gas-vapor phase alone. The latter, being substantially free from
particulates, contains only traces of nicotine.
Measurements of functional residual capacity of the lungs showed that
emphysema was not produced. The strains differed in susceptibility to increaae
in pulmonary resistance (bronchospasm), which was elicited by whole amoke
and to some extent also by the =arvapor phaae, but both strains developed
almost compiete tolerance within ten weeks. A decrease in pulmonary eompii-
ance was reported to be associated with Avo- to teo-week inhafatioo of smoka
from the high-nicotine reference cigarette, but this was not elicited by the sas
vapor phase alone. Effects of acetaldehyde, acrolein and skatole, which ara low-
level, but in other contexts known to be chemically aetive, components of the
gas-vapor phase, were measured in separate but parallel experiments.
Meanwhile, because of suyscstions in the literature that cumulative traces
of inhaled cadmium might be a factor in the etiology of emphysema, a study
similar to that just described was begun with eijarettes "prinsed' with three
levcls of added cadmium compounds.
Because fly ash and nitrogen dioxide are found In the atmospheres of many
cities where chronic pulmonary ailments are prevalent, anorher invcstiptor tx-
posed hamsters for prolonged periods to alrtsospherea containing these eom-
pounds. He too had an impressive series of physiological and morphological test
methods applicable to the hamster, an animal regarded from other studies as
being relatively susceptible to lung damage. The animals were exposed chroni-
cally for about 14 months either to dust alooe, to dust with nitrogen dioxide or
to ambient air. Some of the animals were rr-exposed to ambient air aloos for
two weeks following the other exposurts.
After sacriAce, mcuuremeots were made of static cornpliaoee of the lun=.

'S L
static clastic recoil pressurc, total pulmonary rc.istancc and flow rates, forced
dcllatiun, and morphumetry (or mean lirxar intcrccpts and internal surfacC arca,
a% wcll as general patholugical and hi.tological evaluations. In summary, no
significant abnurmahtics wcre observed in the animals exposed to dust with or
without nitrogen dioxide.
This study drd not produce an animal model for emphysema. In another
study by a difierent investigator, hamsters were exposed to long-term chronic
cigarette snwke inhalation but gross emphysematous changes were not sccn.
been measurcd as well as the mobilization following such aspirations, of ir
creased numbers of recoverable macrophages. The clkcts of tobacco smoke it
halation upon rates of disappearance of viable organisms from the lung in sit
have been reported, and the total engulfment and killing activity of macrophag
populations recovered from smoke-exposed animals arc now being determine
in vitro.
Studiea of Ozone
Ozone, a powerful oxidant and a very prevalent and active constituent of
atmospheric smog, can severely damage the lung as can exposure to abnormally
high levels of oxygen. A scientist sponsored by The Council undertook to study
the effects of these agents in rats and monkeys in order to discover what changes
occur in the lung metabolic and enzymc systems and how they might be prc-
vented or reverscd. When the study is complcted, the information obtuincd
should he useful as background for analogous itudies of tobacco smoke inhala-
tion arid provide a basis for observations on possible interactions between to-
bacco smokc and smog.
Two distinct aspects of ozone effects were found. Short-term, high-lcvcl
exposures (2 to 4 p.p.m.) for two to eight hours destroyed large proportions of
the sulghydryl compounds present in different portions of the lung cells, with
profound lowering in the levels of enzyme activitics involved in cell division
and repair. In contrast, exposures at the level of 0.2 and 0.8 p.p.m. for two to
seven days produced no destruction of sullhydryl compounds or depression
of these enzyme systems; instead, the activity of the systems was increased.
These effects of low levels of ozone may explain in part the tolerance or adap-
tation to such exposures that this scientist and others have noted in animals and
in man. Morphological studies have paralleled these biochemical obscrvations.
Exposures to relatively high concentrations of oxygen are being madc (or
comparison, and studies of tobacco smoke inhalation by rats with or without
previous ozone exposures are now under way.
Preliminary experiments with mice, employing realistic dosages of cigarette
smoke daily for three weeks, showed no histological evidence of major patho-
logical change. The lungs, however, had higher levcls of specific activitics of
the antioxidant cnzymcs, glucosc-6-phospharc dchydrogcnasc, glutathione rc-
ductase " glutathione peroxidase, which may re/lcct adaptive response to oxi-
dants present in the smoke. Other lung biochemical assays have been added to
the protocols; (or example, the effects of oxidants on collagen synthesis. Pulmo-
nary fibrosis is o(ten a sequel to long-term chronic respiratory damage by such
agcnts.
Defense Mechanisms of the Lung
A previous Annual Report (1973) mentiooed studies on the defense me-
chanisnu of the respiratory tract against inhaled particulates, both inanimate
"dusts" and microorganisms, especially by mobilization and (unction of pulmo-
nary macropbatea. Rata of clearanee for aspirated Srayhylococcu.r aureus have
!n/luensa Infections
Influenza infections, still prevalent, result in significant persistent lun
damage in man. A veteran investigator of this problem has published a detailc
description of the sequential effects of influenza PR8-A infections in mia
With the advantages provided by the opportunity to sacrifice animals scriall
at 211 stages of the process, these observations generally have confSrmed and ei
tended those available from human posr-morrcns examinations. A separate rt
view applied these findings to interpretation of potentially serious consequenct
of human influenza and suggested preventive measures that should be applie
to prevent such infections.
A method for producing more consistently a persistent vitamin A deficicnc
in mice made it possible to study the consequences of such deficiency upon th
scquclae of infection. Squamous metaplasia and keratinization of the bronchia
membranes were significantly greater in the animals with little or no hepat~
vitamin A and the post-in(ection lesions showed more extensive epithelia
nodule formation. These and observations from other quarters have renewa
interest in relationships between this vitamin and cancer susceptibility or rc
SlstanCc.
Clinical Surueya of Lung Function
"Captive" populations in the Boston area and on the West Coast are pro
viding the opportunity to describe relations of age, ux, race, light smoking
heavy smoking, industrial exposures, and other facton to pulmonary functiona
changes over an extended period of time, through repetitive reexaminations.
Respiratory Distress Syndrome of Newborn !n fanta
Hyalinc membrane disease in newborn infants, associated with prematurity
maternal diabetes and complications of pregnancy and delivery, produces hitl
mortality. It is due to failure of the inlant lung to expand properly after de
livery and is usually accompanied by formation of a"hyaline membrane." Thi
structure, observed in the alveolar spaces, ducta and bronchioles, consists of de
generated lung surface cells and blood elemenu, and contains large utsounts o
fibrin, an clastic, thread-like, insoluble protein material. The atekctasis (non
expansion) has been attributed to a defSciency in surfactant and the flbrin sc
cumulation to a defective balance between the systems normally responsiblL
for its formation and its removal.
3 9

Only very recently it was discovered that normal hum;,n cmbryonic lung
fibroblast cells (and those of many other mammals) rcgularly produce high
levels of plasminogen activator. This is a protein that converts plasminogen, ,,n
inaetive substance present in the serum, into plasmin, an enzyme that dcstroys
fibrin. The serum from infants with hyaline membrane disease is dcficicnt in
plasntinogen though it is not clear whether this is due to tlie continued produc
tion of the activator or to excessive inhibition of the plasmin produced from it.
In a Council-supported project, plasminogcn activator is being prepared in
quantity from cell cultures; it will be concentratcd, purificd, characterized and
used to produce labeled antibodies for studying its presence and concentration
at specific sites, and its role in normal cells as well as in disease states.
Relevance of this work extends beyond the problem of the respiratory dis-
tress syndrome. It has recently been discovered that normal cells, other than the
exceptional ones of embryonic 1ung, though they quite generally produce very
little pts.smirtogen activator, will nearly always increase this production at least
50-fold when transformed into the malignant state. Indeed, this property may be
a useful indicator of malignant cell transformation. Such transformed cells
show a number of changes in behavior. They will grow on soft agar (unlike
most normal eells), they show Increased migration, they are agglutinated more
readily, they display an altered morphology, and they produce tumors if trans-
planted into mice with low or impaired immune responsivenesa. While normal
embryonic lung cells show a similar ability to grow on soft agar, they do not
show the altered morphology or produoe tumors when so implanted.
Ingenious systems have been designed and applied for studying the bio-
chemical conditions within the cell that govern the production of plasminogen
activator and its accumulation or dispoul in normal lung cells as compared to
canoer cells.
Proteaaeaatad Proteaae Inthibitors in Relation to Emphysema
'TLere are substantial indications that human pulmonary emphysema may
result from "digestioa" of the lunj s elastic structural material by enzymes
(proteaacs) that attack the proteins of which it is composed. One irxllcation is
that paprun, a plant protease mixture that docs not occur naturally in animals,
will neverthekas produce destructive ksioos similar to emphyacma when in-
uillod directly into the lungs of animals of several species.
Another, rcported only a few years ago, is that pcrsons having an ab-
nornully low blood level of a protease inhibitor, originally designated as alpha,-
antitrypsin, are particuLrly likely to develop emphysema at an early age. This
observation rcinforeed the idea that the disease might be caused by proteases
from sorne aource, either internal or exkrnal, if or when their action is not
property controlled or "turned-oft" by an antiprotease.
A third, still more reeent indication is that certain human or dog blood
kukocytes, particularly polymorplsoouckar kukocytes and macrophages from
the periton,eum or lungs, when is+olated, concentrated, broken down, suspended
in a medium, and instilled into dog lunp, produce emphysema. The extent of
the lesions produced is dependent upon the protesae activity of the preparations,
$iaws tbis Lobibilnt is not apocitie for trypsla but binds a number of. proecaaes, ,ipba,-
aatiproteaae is a betur aamo.
c-
and thu.c (rom polyrnorphonuclcar lcukocytcs arc more active than those from~
macruphagc.. (Ioth typcs of cclls concentrate in thc lung in dcfcnu against ,n 1
halcd particulate matter, including infectious organisms. They contain power(ul
protcolytic enzymes packaged in small vesiclcs inside the cell walls and had not
hccn con.idcrcd likcly to harm the lung structure under normal conditions. The
new expcrimcnts, thcrcforc, raised the questions whether cnzyme leakage from
the Icukucyte cells or disintegration of these cells within the lung might bring
the proteascs into direct contact with the lung tissues and thus contribute to
pathogencsis of emphysema under real life conditions, if not properly countered
by protcase inhibitors available in adequate concentrations in the critical areas®
An overproduction of leukocyte protcases or an abnormal access to critical~
zones might contribute to the process. I-
U
A Delicate Balance
A delicate balance between protcolytic and antiproteolytic activities in the
hmg is necessary for defense against infections, but damage to the lungs them-
sclvcs might occur if the balance is disturbed either by overproduction or exces-
sive rclease of protcases, or by underproduction or inadequate access of in-
hibitors.
Extensive studies by many investigators, including several sponsored by
The Council, have shown that alpha,-antitrypsin deficiency follows definite
hereditary patterns in human families. These studies support the concept of an
inherited susceptibility to emphysema and provide one explanation of the em-
pirical observation that the disease lends to "run in families." The picture is
complicated, however, by the existence of several variant forms of this anti-
protease, which differ in theirefficieneiesof antiprolease activity. Atkut twenty
differcnt phenotypes have been described that represent the various possible
combinations of the genes controlling the alphar-antiprotease types and produe-
tion. Moreover, there appear to be familial aggregations showing high em-
physcma predisposition that is unrelated to this antiprotease, suggesting that
other factora not yet described may be involved. There is no reason to suppose,
lur examplc, that antiproteases other than the serum Ipha -xntiprotease and its
variants may not exist in other organs and play a rok in the total picturr. Ad-
ditionally, the role of lung surfactant and its effect, if any, upon protcases and
antiprotcases is not fully understood.
Several grants by The Council have fostered studies of proteases and anti-
protcases in rclation to emphysema. Much eRort has been devoted to purifks-
tion of serum alpha,-antiprotease and its variants so that their structures and
molecular weights could be determirxd, the sequential arrangement of the con-
stituent amino acids worked out and the biochemical modes of action in the
inhibition of protcase activity described. Rsdiolabeled antibodies have been
used to show where these inhibitors bind to tissues. In these studies, compari-
sons with other protease inhibitors from different sources arc helping to define
and describe their likenesses and differertces and especially their specific actions.
The isolation and description of proleases elaborated from lung macro-
phages and granulocytes have also been undertaken to find out which ones arc
most active in attacking lung structural proteins and how they react with in-
hibiton. This has entailed exploration of methods for oollecting, separating and
culturing these several types of cells.
10 11

Detecting the Enrphyserrra-Prone Indiuiduaf
Avowcd aims of these investigators are to develop bettcr methods for de-
tecting high entphysema predisposition in individuals, ma(criats for early diagno-
sis of the discasc and, it is hopcd, agents that might bolster defensive mcchan-
isms in the body and arrest progression of thc discasc.
A related but compatible aim ia to determine whcthcr, how, to what cx-
tent, under what circumstances, and in whom tobacco srnoke exposure could
contribute to the etiology or pathogcnesis, with a view to countering any such
cfiect that may be determined. This aim obviously rcquires studics to elucidate
the uages and mechanisms of pathogcncsis.
In this context a study was supported by The Council to measure levels
of lung kukocyte proteases in groups of persons characterized respectively by
normal, intermediate and low levels of alpha,-antitrypsin. The purpose was to
determine whether there were differences in protcase levels between persons
with and without certain pulmonary functional abnormalities (considered in-
dicative of emphysema) within each of the groups or between those within
these groups who smoked and those who did not. The protcascs assayed were
granulocyte elastase, granulocyte eathepsin and monocyte cathepsin, all of which
are capable of damaging lung structure and all of which are known to he in-
hibited by alphar-antiprotease. No significant differences in the leukocytc pro-
tease levels were found between persons with or without the lung functional ab-
normalities or between those who smoked or did not smoke. Thus, no explana-
tion of the reported associations between smoking and such functional ab-
notmalities emerged from this study. Modified experimental designs may be dc-
vdoped for exploring this question further.
Another research Ieam, supported by The Council, has been concentrating
attention especially upon the proteascs that can be extracted from the poly-
morphonuckar kukocytes and pulmonary macrophagcs. These extracts produce
emphysema-like lesions when instilled into an isolated dog lung maintained in
vitro. Results obtained by this method were shown to be comparablc to those
found in living dop when similarly treated. The introduction of protcascs
throupls the air passages in the living dog was more effective in producing cm-
physema than ia)oction via the blood vessels.
A new antrprotcinaso has been recovcred in washings from dog lungs. It
differs from the alphar-antiproteinau in the blood and from other known pro-
tease inhibitorn, and may function as a regulator of lung protcolysis. In the
model syatem, this antiproteinaae prevented the production of emphysematous
lesions by clastaae (an effoctive ditcatant of the structural lung substance,
elastin), if mixed with an elastare before instillation of the latter into the lung.
Similar antiproleasea have beea rocovered in washings from monkey an.l
human lungs and are being studied similarly.
New Studies of Proteases and Protease Inhibitors
Tltree new studies Ia thia area have boen inaujurated. One of these, at the
biochemical kvrol, involves study ot two proteaaea isolated from human leuko-
cytes, an elauale and a ehyasowrypaia-like proteaae, to characterize their spe-
cific aaivities, their fahibitioo or iaactivatioa by the various naturally occurring
antiprotcascs and by synthetic ones, and their abilities to break down trachco-
hrunchial cartilagc.
'l wo others arc more clinically oriented. In widely separatcd geographical
arcas, I:ugc, unsclcctcd populations of newborn infants of various ethnic origins
will be phcnutypcd with respcct to the alpha, -antiprotease tnentioncd above. The
plra is to conduct rnultifactorial studies of these children and their relatives
prospcctivcly over a period of years in the hope of elucidating the interaction
ul gcnctic and environmental factors.
Conclusion
I~resh clucs and concepts have stimulated a strong wave of new interest and
activity in this long obscure and baffling field of chronic lung discases and pro-
ductrvc rescarch appcars to be reaching an unprecedented level. As The Council
participates in this progress, we will be approaching the objective set forth in
our 1973 Annual Report: to contribute toward meeting the challcngc posed by
the need to establish the etiology and pathogenesis of the chronic obstructive
and other pulmonary diseases.
RoaeaT C. Hocxerr, Prt.D.
Rcscarch Director
L
12 13

Abstracts of Reports
Following arc abstracts, approved by the authors, of reports on new re-
search acknowledging support from The Council that have appeared in scicntific
journals since pubiication of the 1974 Report. 7he name of the recipient is
in italics.
The abstracts are grouped under these headings: 1. Cancer-Related Studies,
11. The Respiratory System, 111. Heart and Circulation, IV. Ncuropharmacology
and Psychophysiology, V. Pharmacolo;;y, VI. Immunology and Adaptive Mc-
ehanisms, VI1. Epidemiology.
I. Cancer,Related Studies
CORRELATION BETWEEN BALANCE OF SPECIFIC CHROMOSOMES
AND EXPRESSION OF MALIGNANCY IN HAMSTER CELLS
In cell culture, abnormal chromosome patterns occur rapidly in hamster
fetal (HF) cells after treatment by various polycyclic hydrocarbons. The close
association between this ancuploidy and malignant transformation has been dis-
euascd, and it has been suggested recently that malignant cell transformation
and its reversion are determined by the balance between specific chromosomes
containing information for either the "expression" or "suppres,sion" of malig-
nancy. In this study. HF cells transformed by 1-p-D-arabinofuratsosylcytosine
(ara-C) and dimethylnitroaamine (DMN) were used to see if a specific chromo-
some imbalance could be correlated with the expression of malignancy in trans-
formed cells. Four ara-C- and one DMN-transformcd Syrian hamster ccll lines
were established. All produced tumors when inoculated into newborn hamsters.
Speciffe chromosonse changes were observed in these lines which were con-
aistent with changes desaibed by other investigators. Clones that had either
high or low malignant potential were derived from two fibrosarcomas produced
by one of the ara-C-transformed cell lines. The expression of malignancy in
these clortes was auoeiatod with an exceu 5, chromosomes over 7, chromo-
,omes. It is importaat to determine it the same relationship between the balance
of spocillc chromosomea and the expression of malignancy can be extended to
other mammalian species, particularly the murine and human systems. Some of
this work is now in progress.
Beaedicr, W. F. er al.
Journal of rlra Natfonal Cancer lnsrlrrus 34(1) :137-162, 1975.
Ot3sar aupportr National Caacer Imtitute.
From the Divisioo of Hematology-Oncology, Departrnent of Pediatrics, Chil-
dren's Hospita) of Los Angeles; the Pediatric Oncology Program, University of
Southern California School of Medieine, Los Angeles; and the Department of
Viral-Chemical Oneoiogy, 1llcrobiological Aasociates, Inc., Bethesda, Md.
STRAIN DIFFERENCES IN THE RESPONSE OF INI3RED SYRIAN
HAMSTERS TO CIGARETTE SMOKE INHALATION
Striking diRcrcnccs occur among diflcrent lines of hamstcr: with respect
to the susccptihility to acute toxic ef1'ects of smoke and to the hypcrplastic
response of the larynx to smoke. In this study, male hamsters, 102 from each
of two inbred lines, were exposed to cigarette smoke twice a day, five days/
week (or up to 100 weeks, in a modified Walton reverse-smoking machine.
Sixty sham-smoked and 60 cage-held controls were used for each strain. Smoke
exposure for up to 100 weeks had no effect on mortality in either strain, but
reduced body weight. Carboxyhemoglobin kvels increased markedly imnxdi-
atcly after each smoke exposure but returned to baseline levels in less than 24
hours. Serum triglyceride kvels and virus profiles of srnoke-exposed animals
were unchanged. Chronic smoke exposure increased relative weight of the
lungs and heart in both strains, but to different degrees. Over 90% of the
smoke-exposed animals of both strains showed hyperplastic or steoplastic
changes in the larynx. However, microinvasive cancer was nearly five times
more frequent in one strain than in the other. In the inbred line more stu-
ccptible to laryngeal hyperplasia, two animals developed nasopharyngeal tumors,
one of which was malignant. Smoke exposure induced rare benign squamous
papillomas in the air passages of both strains. The strain less susceptible to
laryngeal hyperplasia exhibited more pulmonary adctsomatosis, but its incidusce
was not significantly affected by smoke exposure.
Bernfeld, P., Homburger, F. and Russfkad, A. B. (Bio-ReJaarch Conrrdranu,
Inc.)
Journal o/ the National Canccr lnuiru/e 53 (4) :1 141-1157, 1974.
From Bio-Rcsearch Consultants, Inc., Cambridge, Masa.
MODF_S OF GROWTII AND SPREAD OF A TRANSPLANTABLE,
VIRUS-PRODUCING MURINE (MOLONEY) SARCOMA:
KARYOTYPIC ANALYSES
According to karyotypic analyses, cell clones from a virus-prnducing, uans-
plantabk murine (Molortcy) sarcoma line (MSC) contained a aet of stabk,
structurally rearranged "marker" chromosomes. These identifying markers were
not present in cells newly transformed by murine sarcoma virus (MSV). Tltus,
after MSC injection, it was possible to determine if there was any causal na
lationship between MSV produced in vivo and the subsequent development of
primary and secondary neoplasms. Each adult and neonatal mouse given 104
MSC developed a progressing primary sarroma. Many had secondary pul-
monary neoplasms as well, and some neonates developed secondary apken and
periosteal tumon. All the 879 metaphase spreads prepared from primary sar-
comas and secondary pulmonary neoplasms contained MSC marker chramo-
somes. In contnst, cells cxplanted from a perlaateal neonatal mousc turnor uni-
formly lacked such markers, even tboujh the primary sarcoma of the same
mouse consisted of MSC cells exclusively. Sirtillarly, tsooe of the 180 meuphase
spreads from sarcoma virus-indueod primary tuawt>e contained MSC marker
chromosomes. Primary sarcomas and seeoodary pulmonary tseopaasnts, the
14 13

lesions most frequently encountered in this system, developed by replication
and metastasis of MSC eells, rapectively. Virus recruitment of new tumor cells
appears to have only a ntinor role in the spread of sarcomas in neonatal mice.
Russell, S. W., Franckc, U., Bucttncr, L. and Cochrane, C. C.
lournal of the National Cancer lntriture 53 ( 3):801-806, 1974.
Other support: National Institute of Allergy and Infectious Diseases, Nation-
al Institute of Child Health and Human Development, National Foundation -
March of Dimes, and American Heart Association.
From the Department of Experimental Pathology, Scripps Clinic and Research
Foundation, and the Department of Pedistria. University of California at San
Diego School of Medicine. La lolla.
THE ONCORNAVIRUS GLYCOPROTEIN gp69/7l: A CONSTITUENT
OF THE SURFACE OF NORMAL AND MALIGNANT THYMOCYTES
The gp69/71 glycoprotein, which has group, type and interspecies anti-
genic determinants, is one of the important antigens involved in the neutraliza-
tion of virus by antibody. In this report, the authors extended their previous
studies of oncornavirus-related protcins and showed that gp69/71 is present on
the surface of virus-induced lymphoma cells, as well as on virus particles, and
the surface of normal thymus cells of some mice. In gp69/71- mice, conver-
sion to the gp69/71 phenotype accompanied leukcmogcnesis. An interesting
difference in apparent mokcular size of virus-related antigens of the 70.000
dalton size clasa was detected in lymphoma cells present in involved spleens as
compared to those found in involved thymuses. Also, it was shown that mice
infected as neonates with Scripps leukemia virus make antibody to gp69/71 and
some make antibodies to molecules associated with the surface of their own
tumors. Results of this study show that ntibody to gp69/71 can react with
the surface of three independent structures with rcplicativc potential (vints,
rsonaal thymocytes and tumor cells). Such antibody may have different con-
aoquencu for oocogeneaia, depending on the localization of the antigen.
Del Villano, B. C.. Navt, B., Croker, B. P., Lerner, R. A. and Dixon, F. 1.
The lo.wssaf o/ EapsrbnentaJ iiledkine 141 (1) :172-187, 1975.
Other support: National Foundation - March of Dimcs, U. S. Public Health
Service assd the National Cancer (mtitute.
From the Department of Imraunopathology, Scripps Clinic and Research Foun-
datioo, La Jolla, CaL
CELL-MEDIATED IMMUNITY AFTER INTRATRACHEAL
EXPOSURE TO 3-METHYLCHOLANTHRENE, AND ITS
IIELATIONSHIP TO TUMOR TRANSPLANT GROWTH
IN C3H/f MAI MICE
Immstnologfc deficiencioa an often noted In assoctation with cancer, but
the eaact nauure of this relatiombip has oot boea fully characterizod. The rela-
16
i
tivc irnmunocompelence of an individual, however, definitely plays a major role
in the uldmate susceptibility or resistance to cancer. Numerous studies support
the concept that it is the cell-mediatcd immunity (CMI) which is largely re-
sponsible for thc body's defcnsc against cancer. Here, C31i/f Mai mice were
instilled intratracheally with MCA (four 500 yg doses of 3-methykholanthrene
in corn oil, at weekly intervals) as part of an investigation aiming to determine
the levels of chemicals at which tumorigenesis occurs in various strains and
whether the animals' immunocompetcnce is affected. Effects on CMI were as-
scssed three days after each treatment by mcuuring DNA synthesis rates withez
sli-thymidine in allogencic and spleen lymphocyte cultures. Spleen, thymus and
lung were weighed and peripheral blood leukocytes counted. Syngeruic and ~.,
allogeneic tumor cells were inoculated into control and test mice to determineo
whether CMI data are biologically relevant to tumor growth. The CMI and
tissue responses were again evaluated 7, 14 and 28 days later. Preliminary data
based on spleen lymphocyte responsa to phytohemagglutinin, pokeweed mito-
gen and allogencic antigen indicate that MCA suppresses CMI. This effect was
most pronounced in response to pokeweed mitogen, however, indicating that
the B-lymphocytcs were most afCected. Although only syngeneic transplants
were succcssful, lymphocyte cultures from all tumor-inoculated mice demon-
stratcd enhancement of T-cell activity and thus CMI, regardless of MCA ex-
posure. It will be of intcresl to follow the kinetics of this effect in the hou and
compare it to the rate of tumor transplant growth. This study suggests that pul-
monary exposure to polycyclic hydrocarbons in mice provides a useful model
for characterizing the underlying mechanism of respiratory carcinogenesis and
host immunocompetence.
Demoise, C. F., Kouri, R. E. and Whitmire, C. E. (Microbiological Associates)
In: Karbe. E. and Park, 1. F. (eds.): E.rprrirrknral Lung Cancer. Carcino-
gfncsis and Diourrays, New York: Springcr-Vcrlag, 1974, pp. 72-80.
From the Department of Experimental Oncology, Viral-Chemical Carcino-
genesis Section, Microbiological Aasociates, Inc., Bcthesda, Md.
ARYL HYDROCARBON HYDROXYLASE INDUCTION IN HUMAN
LYMPHOCYTE CULTURES BY 2,3,7,8-TETRACHLORODIBENZO-p-
DIOXIN
Recent studies have shown that 2,3,7,8-tetrachlorodibenzo-p-dioxia
(TCDD), a toxic contaminant formed during commercial synthesis of the
herbicide 2,4,5-trichlorophcnoxyacetic acid, is about 30,000 times more potent
than )-methylcholanthrcrx (MC) as an inducer of aryl hydrocarbon hydroryl-
ase (AFIH) activity in the rat liver. Furthermore, In contrast to MC or A-
naphahoflavone, it fully induces the hydroxylase activity in the liver, kidney,
bowel, lung and skin of so-called "nonrcsponsive" mice. The biological half-life
of TCDD in the rat is about 17 days, with the induced hydroxy)ase activity and
associated cytochrome P,450 remaining elevated for more than 35 days. Thus.
TCDD may become a scrious environmental contaminant foe man. Evidence
for the appearance of this toxic agent In the food chain has already been re-
ported. This report indicates that individuals having genetically lower basal and
MC-inducibk hydroxylase activities also have lower TCDD-inducibk bydroxyl-
17
